ArticleAnnals of the rheumatic diseases2022

Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors.

Vega Jovani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.